Oncostatin M: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
'''Oncostatin M''' (OSM) is a [[ | == Oncostatin M == | ||
[[File:hosm.jpg|thumb|right|Oncostatin M structure]] | |||
'''Oncostatin M''' (OSM) is a [[cytokine]] belonging to the [[interleukin-6]] (IL-6) family, which plays a significant role in the regulation of [[inflammation]], [[hematopoiesis]], and [[oncogenesis]]. It is produced by a variety of cells, including [[activated T cells]], [[macrophages]], and [[dendritic cells]]. | |||
== Structure == | |||
Oncostatin M is a glycoprotein with a molecular weight of approximately 28 kDa. It is encoded by the [[OSM gene]] located on chromosome 22 in humans. The protein consists of 209 amino acids and shares structural similarities with other members of the IL-6 family, such as [[leukemia inhibitory factor]] (LIF) and [[ciliary neurotrophic factor]] (CNTF). | |||
== Function == | == Function == | ||
Oncostatin M | Oncostatin M exerts its effects by binding to specific [[receptors]] on the surface of target cells. It primarily signals through the [[OSM receptor]] (OSMR) and the [[gp130]] receptor subunit, which are shared with other cytokines in the IL-6 family. Upon binding, OSM activates the [[JAK-STAT signaling pathway]], leading to the transcription of various genes involved in cell proliferation, differentiation, and survival. | ||
== | === Role in Inflammation === | ||
OSM is a potent mediator of [[inflammatory responses]]. It can induce the expression of [[acute phase proteins]] and [[pro-inflammatory cytokines]] such as [[interleukin-1]] (IL-1) and [[tumor necrosis factor-alpha]] (TNF-_). OSM also enhances the recruitment of [[leukocytes]] to sites of inflammation by upregulating the expression of [[adhesion molecules]] on [[endothelial cells]]. | |||
=== Role in Hematopoiesis === | |||
In the context of [[hematopoiesis]], OSM supports the proliferation and differentiation of [[hematopoietic stem cells]] and progenitor cells. It has been shown to synergize with other cytokines like [[granulocyte colony-stimulating factor]] (G-CSF) to promote the development of [[myeloid]] and [[erythroid]] lineages. | |||
=== Role in Oncogenesis === | |||
OSM has a dual role in [[cancer]]. It can inhibit the growth of certain [[tumor]] cells, such as [[melanoma]] and [[breast cancer]] cells, by inducing [[cell cycle arrest]] and [[apoptosis]]. However, in other contexts, OSM may promote [[tumor progression]] and [[metastasis]] by enhancing [[angiogenesis]] and [[extracellular matrix]] remodeling. | |||
== Clinical Implications == | |||
Due to its involvement in various physiological and pathological processes, OSM is a potential target for therapeutic intervention. Modulating OSM activity could be beneficial in treating [[inflammatory diseases]], [[autoimmune disorders]], and certain types of cancer. However, the complex and context-dependent nature of OSM's effects necessitates careful consideration in the development of OSM-targeted therapies. | |||
== Related pages == | |||
* [[Cytokine]] | * [[Cytokine]] | ||
* [[Interleukin 6]] | * [[Interleukin-6]] | ||
* [[ | * [[JAK-STAT signaling pathway]] | ||
* [[ | * [[Hematopoiesis]] | ||
* [[ | * [[Oncogenesis]] | ||
[[Category:Cytokines]] | [[Category:Cytokines]] | ||
Latest revision as of 04:01, 13 February 2025
Oncostatin M[edit]
Oncostatin M (OSM) is a cytokine belonging to the interleukin-6 (IL-6) family, which plays a significant role in the regulation of inflammation, hematopoiesis, and oncogenesis. It is produced by a variety of cells, including activated T cells, macrophages, and dendritic cells.
Structure[edit]
Oncostatin M is a glycoprotein with a molecular weight of approximately 28 kDa. It is encoded by the OSM gene located on chromosome 22 in humans. The protein consists of 209 amino acids and shares structural similarities with other members of the IL-6 family, such as leukemia inhibitory factor (LIF) and ciliary neurotrophic factor (CNTF).
Function[edit]
Oncostatin M exerts its effects by binding to specific receptors on the surface of target cells. It primarily signals through the OSM receptor (OSMR) and the gp130 receptor subunit, which are shared with other cytokines in the IL-6 family. Upon binding, OSM activates the JAK-STAT signaling pathway, leading to the transcription of various genes involved in cell proliferation, differentiation, and survival.
Role in Inflammation[edit]
OSM is a potent mediator of inflammatory responses. It can induce the expression of acute phase proteins and pro-inflammatory cytokines such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-_). OSM also enhances the recruitment of leukocytes to sites of inflammation by upregulating the expression of adhesion molecules on endothelial cells.
Role in Hematopoiesis[edit]
In the context of hematopoiesis, OSM supports the proliferation and differentiation of hematopoietic stem cells and progenitor cells. It has been shown to synergize with other cytokines like granulocyte colony-stimulating factor (G-CSF) to promote the development of myeloid and erythroid lineages.
Role in Oncogenesis[edit]
OSM has a dual role in cancer. It can inhibit the growth of certain tumor cells, such as melanoma and breast cancer cells, by inducing cell cycle arrest and apoptosis. However, in other contexts, OSM may promote tumor progression and metastasis by enhancing angiogenesis and extracellular matrix remodeling.
Clinical Implications[edit]
Due to its involvement in various physiological and pathological processes, OSM is a potential target for therapeutic intervention. Modulating OSM activity could be beneficial in treating inflammatory diseases, autoimmune disorders, and certain types of cancer. However, the complex and context-dependent nature of OSM's effects necessitates careful consideration in the development of OSM-targeted therapies.
